Teacher Retirement System of Texas Decreases Position in Biogen Inc. (BIIB)

Marco Green
November 15, 2017

Signaturefd LLC now owns 718 shares of the biotechnology company's stock valued at $174,000 after buying an additional 492 shares during the period. Its position stood at $197,265,000 an increase of 2.4% as of the end of the quarter. Biogeninc. now has $66.77 billion valuation.

Panagora Asset Management Inc decreased Entergy Corp (NYSE:ETR) stake by 232,731 shares to 28,129 valued at $2.16M in 2017Q2. About 21,244 shares traded. OSI Systems, Inc. (NASDAQ:OSIS) has risen 56.65% since November 13, 2016 and is uptrending.

Kazazian Asset Management Llc decreased its stake in Biogen Inc (BIIB) by 41.17% based on its latest 2017Q2 regulatory filing with the SEC. The Tirschwell & Loewy Inc holds 74,704 shares with $20.27 million value, down from 76,580 last quarter. After $6.31 actual earnings per share reported by Biogen Inc for the previous quarter, Wall Street now forecasts -12.04% negative EPS growth. Caxton Assocs Lp holds 0% or 1,500 shares. The company's revenue was up 4.1% on a year-over-year basis. It has underperformed by 16.70% the S&P500.

Investors sentiment decreased to 0.88 in Q2 2017. Its down 0.16, from 1.04 in 2017Q1. The Gendell Jeffrey L holds 780,000 shares with $18.92 million value, up from 280,000 last quarter. 78 funds opened positions while 277 raised stakes. The company saw 4.46 million shares trade hands over the course of the day. Hightower Advsr Lc invested in 0.07% or 29,196 shares.

Teacher Retirement System of Texas reduced its stake in shares of Biogen Inc. 25,000 were reported by Healthinvest Ab. Reliance Tru Of Delaware invested in 0.53% or 12,680 shares. The stock witnessed -6.86% declines, 8.53% gains and 20.08% gains for the 1-month, 3-month and 6-month period, respectively. Perkins Coie Co reported 0.06% in Biogen Inc (NASDAQ:BIIB). Cap Investment Advisors invested in 0.02% or 1,010 shares. American Assets Capital Advisers owns 921,719 shares or 6.09% of their USA portfolio.

The market experts are predicting a 38.51% rally, based on the high target price ($430) for Biogen Inc. shares that is likely to be hit in the 52 weeks. Peoples Services stated it has 0% of its portfolio in Biogen Inc (NASDAQ:BIIB). Cibc Markets Inc holds 0.05% or 46,600 shares. Amalgamated Bancshares has invested 0.22% in Biogen Inc (NASDAQ:BIIB). It worsened, as 81 investors sold BIIB shares while 321 reduced holdings. The correct version of this article can be viewed at https://www.truebluetribune.com/2017/11/13/biogen-inc-biib-given-a-400-00-price-target-by-mizuho-analysts.html. ValuEngine cut Biogen from a "buy" rating to a "hold" rating in a research report on Friday, September 1st. Therefore 67% are positive.

Other analysts also recently issued research reports about the stock. Daiwa Secs Grp Inc holds 0.01% of its portfolio in Biogen Inc (NASDAQ:BIIB) for 6,230 shares. The firm has "Neutral" rating by UBS given on Wednesday, October 25. The rating was maintained by Cowen & Co with "Hold" on Tuesday, October 24. The rating was maintained by Nomura with "Buy" on Friday, July 14. Vetr downgraded shares of Biogen from a "hold" rating to a "sell" rating and set a $265.77 price objective for the company.in a research report on Monday, July 25th. Finally, Morgan Stanley reiterated a buy rating on shares of Biogen in a research note on Tuesday, October 17th. The firm has "Hold" rating by RBC Capital Markets given on Wednesday, October 25. Hellman Jordan Management Inc Ma invested in 1.22% or 2,087 shares. Hanson Mcclain Inc reported 0% stake.

Since June 9, 2017, it had 0 insider purchases, and 1 insider sale for $277,840 activity.

More notable recent Biogen Inc (NASDAQ:BIIB) news were published by: Nasdaq.com which released: "Meridian Wealth Management, LLC Buys United States Steel Corp, Biogen Inc ..." on November 01, 2017, also Seekingalpha.com with their article: "Biogen Spin-Off Bioverativ Shows Strong Performance And Robust Potential" published on October 25, 2017, Nasdaq.com published: "Biogen Inc". Leading up to this report, we have seen a 19.86% rise in the stock price over the last 30 days and a 22.44% increase over the past 3 months. Marketwatch.com's article titled: "90.29" and published on October 16, 2010 is yet another important article. Ten research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company's stock. Therefore 35% are positive. PulteGroup had 55 analyst reports since September 11, 2015 according to SRatingsIntel. The company was reinitiated on Monday, October 23 by PiperJaffray. On Monday, April 4 the stock rating was downgraded by KeyBanc Capital Markets to "Sector Perform". The company was initiated on Friday, February 5 by Leerink Swann. Biogen has an average rating of "Buy" and an average target price of $341.89. The rating was maintained by RBC Capital Markets on Wednesday, October 7 with "Outperform". The stock of PulteGroup, Inc. (NASDAQ:OSIS) earned "Buy" rating by Benchmark on Tuesday, June 21. BB&T Capital upgraded the stock to "Buy" rating in Monday, May 9 report.

Other reports by Click Lancashire

Discuss This Article